Oct. 16, 2020 — Pfizer will not apply for emergency authorization of its coronavirus vaccine earlier than the third week in November, the corporate’s chief govt mentioned in an announcement posted to Pfizer’s web site on Friday.

The reversal from the corporate’s earlier claims that it will apply for the approval in October is a blow to U.S. President Donald Trump, who repeatedly mentioned {that a} vaccine could be accessible earlier than Election Day on Nov. 3, The New York Instances reported.

Despite the fact that Pfizer might have preliminary knowledge concerning the vaccine’s effectiveness by the top of October, gathering security and manufacturing knowledge would take till a minimum of the third week of November, Dr. Albert Bourla mentioned within the assertion.

Pfizer’s announcement was welcomed by some scientists.

“That is good, actually good,” Dr. Eric Topol, a scientific trial professional at Scripps Analysis in San Diego, informed The Instances. He was one in every of 60 public well being officers and different medical specialists who despatched a letter to Pfizer urging it to not rush its vaccine, The Instances reported.

Pfizer is one in every of 4 firms with a coronavirus vaccine in late-stage scientific trials in america. The others are Moderna, AstraZeneca and Johnson & Johnson. Pfizer has given essentially the most optimistic timeline, whereas the opposite three have mentioned later this yr is extra possible.



WebMD Information from HealthDay



Copyright © 2013-2020 HealthDay. All rights reserved.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here